The market for pyelonephritis treatments presents opportunities in novel drug development, emphasizing advanced ESBL coverage and efficacy under acidic conditions. Key players include Wockhardt and ...

Credit: Getty Images Researchers assessed patients with uncomplicated urinary tract infections to determine factors associated with extended-spectrum β-lactamase-producing uropathogens.

Please provide your email address to receive an email when new articles are posted on . Using Clinical and Laboratory Standards Institute, or CLSI, revised breakpoints and omitting extended-spectrum ...

An international study led by a Rutgers scientist comparing new and older treatments against complicated urinary tract infections has found a new drug combination to be more effective, especially ...

An international study led by a Rutgers scientist comparing new and older treatments against complicated urinary tract infections has found a new drug combination to be more effective, especially ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...